TG01/GM-CSF and adjuvant gemcitabine in patients with resected RAS-mutant adenocarcinoma of the pancreas (CT TG01-01): a single-arm, phase 1/2 trial

por Palmer, Daniel H., Valle, Juan W., Ting Ma, Yuk, Faluyi, Olusola, Neoptolemos, John P., Jensen Gjertsen, Trine, Iversen, Berit, Amund Eriksen, Jon, Møller, Anne-Sophie, Aksnes, Anne-Kirsti, Miller, Robert, Dueland, Svein
Publicado 2020